✦ LIBER ✦

Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer

✍ Scribed by T. A. Traina; I. Poggesi; M. Robson; A. Asnis; B. A. Duncan; A. Heerdt; C. Dang; D. Lake; M. Moasser; K. Panageas; P. Borgen; L. Norton; C. Hudis; M. N. Dickler

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 417 KB
Volume: 111
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-007-9787-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of raloxifene among women with a his

Use of raloxifene among women with a history of breast cancer

✍ Laurel A. Habel; Alice Pressman; Bruce Ettinger; Stephen Sidney; Betty Suh-Burgm 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 190 KB

Effects of raloxifene on sex steroid hor

Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer

✍ Harriet Johansson; Bernardo Bonanni; Frederique Mariette; Massimiliano Cazzaniga 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 194 KB

Use of aromatase inhibitors in postmenop

Use of aromatase inhibitors in postmenopausal women with advanced breast cancer

✍ Roseman, Barry J.; Buzdar, Aman U.; Singletary, S. Eva 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

Surgeons have been involved in the management of metastatic breast cancer since the technique of ovarian ablation was introduced in 1896. However, as newer hormonal and chemotherapeutic regimens were developed, drug therapy gradually replaced surgery as the preferred treatment for metastatic breast

Treatment of advanced breast cancer in p

Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione

✍ Robert C. Stein; Mitchell Dowsett; Anthea Hedley; Joanna Davenport; Jean-Claude 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 372 KB

Efficacy and tolerability of moexipril a

Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension

✍ E. Agabiti-Rosei; E. Ambrosioni; A. Pirelli; M. Stimpel; A. Zanchetti; the MADAM 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 111 KB

Cost-effectiveness of switching to exeme

Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer

✍ Nancy A. Risebrough; Shailendra Verma; Maureen Trudeau; Nicole Mittmann 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## BACKGROUND. Sequential tamoxifen/exemestane therapy reportedly improves disease‐free survival in women with primary breast cancer compared with continued tamoxifen therapy. The objective of the current study was to assess the cost‐effectiveness of switching to exemestane after 2 to